Clinical trial
Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for…
NCT00165139 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00165139 |
|---|---|
| Title | Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas |
| Official title | Double Dose Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Stage Neuroblastoma and Sarcomas |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Boston Children's Hospital Children's Hospital of Philadelphia |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroblastoma, Ewings Sarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma |
| Intervention type | Drug |
| Interventions | Vincristine, Cyclophosphamide, Adriamycin, Etoposide (VP-16), Cisplatin, Carboplatin, Melphalan, Ifosfamide, G-CSF (granulocyte-colony stimulating factor), Mesna |
| Enrollment | 20 |
| Start date | Jan 1, 1996 |
| Primary completion | Nov 1, 2000 |
| Completion | Feb 1, 2009 |
| First posted | Sep 14, 2005 |
| Last update posted | Nov 2, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: